Pascal Juillerat

14PUBLICATIONS
63CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMetabolic medicineMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Nov 05, 2025
Efficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn's Disease.

Marla C Dubinsky, Geert D'Haens, Olivier Dewit

|Jun 10, 2025
Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn's disease: results from the phase 3 VIVID-1 study.

Miguel Regueiro, Monika Fischer, Peter Bossuyt

|Nov 15, 2023
Treatment of Antibiotic Refractory Chronic Pouchitis With JAK Inhibitors and S1P Receptor Modulators: An ECCO CONFER Multicentre Case Series.

Davide Giuseppe Ribaldone, Giulia Testa, Bram Verstockt

|Aug 12, 2023
Machine Learning in Antibody Diagnostics for Inflammatory Bowel Disease Subtype Classification.

Christiane Sokollik, Aurélie Pahud de Mortanges, Alexander B Leichtle

|Sep 02, 2022
ECCO Topical Review: Roadmap to Optimal Peri-Operative Care in IBD.

Shaji Sebastian, Jonathan P Segal, Charlotte Hedin

|Aug 27, 2021
Modulation of the Mucosa-Associated Microbiome Linked to the PTPN2 Risk Gene in Patients with Primary Sclerosing Cholangitis and Ulcerative Colitis.

Luisa Denoth, Pascal Juillerat, Andreas E Kremer

Pageof 3

Frequent Collaborators

4 joint publications

Bahtiyar Yilmaz

3 joint publications

Valérie Pittet

2 joint publications

Michael Scharl

2 joint publications

Pierre Michetti